---
title: "LBRX.US (LBRX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LBRX.US/news.md"
symbol: "LBRX.US"
name: "LBRX.US"
parent: "https://longbridge.com/en/quote/LBRX.US.md"
datetime: "2026-03-16T11:47:42.399Z"
locales:
  - [en](https://longbridge.com/en/quote/LBRX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LBRX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LBRX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/LBRX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/LBRX.US/news.md)


# LBRX.US (LBRX.US) — Related News

### [LB Pharmaceuticals adds neuroscience leader to board, governance](https://longbridge.com/en/news/278558784.md)
*2026-03-10T12:49:48.000Z*
> LB Pharmaceuticals, Inc. has appointed Robert A. Lenz, M.D., Ph.D., a veteran in neuroscience drug development, to its B

### [LB appoints Robert A. Lenz to board; Gad Soffer promoted to Chief Operating and Business Officer](https://longbridge.com/en/news/278555525.md)
*2026-03-10T12:23:00.000Z*
> LB Pharmaceuticals Inc. has appointed Robert A. Lenz as a Class I director on its Board and promoted Gad Soffer to Chief

### [LB Pharmaceuticals Inc's (NASDAQ:LBRX) Lock-Up Period Set To End  on March 10th](https://longbridge.com/en/news/277568731.md)
*2026-03-03T06:03:44.000Z*
> LB Pharmaceuticals Inc's (NASDAQ:LBRX) lock-up period will end on March 10th, allowing insiders and major shareholders t

### [10:32 ETBreckenridge launches Pomalidomide Capsules, strengthening its oncology portfolio](https://longbridge.com/en/news/277490980.md)
*2026-03-02T15:33:56.000Z*
> Breckenridge Pharmaceutical, Inc. has launched Pomalidomide Capsules, a generic version of Pomalyst®, enhancing its onco

### [LB Pharmaceuticals Raises $100 Million in Private Placement with Shares and Pre-Funded Warrants Issued](https://longbridge.com/en/news/274977918.md)
*2026-02-05T13:04:06.000Z*